Browsing Tag
Indian pharmaceutical company
6 posts
Senores Pharmaceuticals (NSE: SENORES) launches Deferiprone Tablets in U.S. with Dr. Reddy’s Laboratories
Find out how Senores Pharmaceuticals Limited’s Deferiprone launch in the U.S. is reshaping its generics growth strategy. Read more for expert analysis!
Dr. Reddy’s company profile: Respiratory, generics, and global drug pipeline in 2025
Explore Dr. Reddy’s FY25 financials, drug pipeline, and global expansion strategy—see why it’s gaining attention in pharma investment circles.
Is Lupin doubling down on respiratory care? A look at its global inhalation drug pipeline
Lupin is expanding its respiratory care pipeline with global deals and inhaler innovation. Explore its strategy in COPD, asthma, and beyond.
Lupin signs China licensing deal for COPD drug Tiotropium DPI with Sino Universal Pharmaceuticals
Lupin enters China’s COPD market with a Tiotropium DPI licensing deal. Learn how this move shapes its global respiratory growth strategy.
Dr. Reddy’s Laboratories takes $620m gamble in Switzerland: Could this bold move dominate Europe?
Dr. Reddy’s Laboratories, the Indian pharmaceutical giant, has solidified its European ambitions with a monumental $620 million investment…
Marksans Pharma’s Relonchem wins UK MHRA approval for Loperamide 2 mg capsules
Marksans Pharma’s Relonchem secures UK MHRA nod for Loperamide 2 mg capsules, boosting its UK market reach with Goa-made generics.